NCT06900114 2026-03-05
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
Institute of Hematology & Blood Diseases Hospital, China
Completed
Clinical Trials
16 trialsNCT05386355 2025-03-11
MoVeUP
IDeA States Pediatric Clinical Trials Network
Phase NA Completed
NCT06469138 2025-01-29
8479217
BerGenBio ASA
Phase 1 Completed
NCT05148806 2024-12-09
MELODY
Imperial College London
Completed
NCT05058339 2024-09-19
Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer
M.D. Anderson Cancer Center
Completed
NCT05422937 2024-05-22
SPLaT-19
Keele University
Completed
NCT04666025 2024-04-08
SARS-CoV-2 Donor-Recipient Immunity Transfer
City of Hope Medical Center
Completed
NCT04852796 2023-08-30
HEMVACO
Centre Hospitalier de Cornouaille
Completed
NCT04630015 2023-05-09
Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth
University of California, San Francisco
Completed
NCT04422470 2023-01-26
CHRONOS19
National Research Center for Hematology, Russia
Completed
NCT04932967 2022-06-22
Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT04330261 2022-05-17
PERN-COVID-19
University of Calgary
Completed
NCT04760184 2022-02-08
AutoCOVID-19
Uppsala University
Completed
NCT04652505 2022-01-14
Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study
M.D. Anderson Cancer Center
Completed
NCT04419623 2021-05-12
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer
Telios Pharma, Inc.
Phase 1 Completed
NCT04745416 2021-02-09
Clinical Characteristics of Patients With Leukemia and COVID-19
Hospital General de Mexico
Completed